학술논문
Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor
Document Type
Article
Author
Kochenderfer, J.N.; Dudley, M.E.; Kassim, S.H.; Somerville, R.P.T.; Carpenter, R.O.; Maryalice, S.-S.; Yang, J.C.; Phan, G.Q.; Hughes, M.S.; Sherry, R.M.; Raffeld, M.; Feldman, S.; Lu, L.; Li, Y.F.; Ngo, L.T.; Nathan, D.-A.N.; Morton, K.E.; Toomey, M.A.; Rosenberg, S.A.; Chen, C.C.; Kranick, S.M.; Nath, A.; Goy, A.; Feldman, T.; Spaner, D.E.; Wang, M.L.
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 20 February 2015, 33(6):540-549)
Subject
Language
English
ISSN
15277755
0732183X
0732183X